Sunitinib malate is a small molecule that targets multiple receptor tyrosine kinases and blocks their activity. Receptors targeted by sunitinib are implicated in tumor vascularization and are overexpressed by vascular tumors encountered in infants, namely, hemangiomas. Of note is that there is still no definitive treatment for these commonly occurring tumors of infancy. The purpose of this study was to investigate the effects of sunitinib malate on hemangioma using endothelial cells isolated from a murine model of the neoplasm (sEnd.2). The effects of the drug on cell growth were evaluated using the crystal violet assay and flow cytometry, while the scratch assay was employed to measure cell migration. Proteins associated with cell migration and angiogenesis were detected using western blotting. Sunitinib was investigated further to determine its effects on the production of reactive oxygen species, a parameter associated with the promotion of neovascularization in tumors. The results showed that sunitinib significantly reduced the growth of sEnd.2 cells by causing the cells to accumulate in the sub-G1 phase of the cell cycle, and also induced a significant decrease in the migration of these hemangioma cells (P < 0.05). The western blot assay showed a decrease in the expression of adhesion proteins, focal adhesion kinase and paxillin at IC50 doses, although the expression of cadherin did not change significantly (P < 0.05). In addition, transforming growth factor-β1 (TGF-β1) expression was decreased in sunitinib-treated cells at the same dose. The adhesion proteins as well as TGF-β1 regulate cell movement and have been implicated in tumor progression. Thus, sunitinib malate may have potential in the treatment of hemangiomas.

• MeSH
• analýza buněčné migrace statistika a číselné údaje   MeSH
• buněčný cyklus MeSH
• buňky - růstové procesy účinky léků   MeSH
• endoteliální buňky účinky léků   MeSH
• fokální adhezní tyrosinkinasy MeSH
• hemangiom * farmakoterapie   MeSH
• modely u zvířat MeSH
• myši MeSH
• průtoková cytometrie MeSH
• statistika jako téma MeSH
• sunitinib * farmakologie   terapeutické užití   MeSH
• vaskulární endoteliální růstové faktory MeSH
• viabilita buněk MeSH
• výsledek terapie MeSH
• western blotting MeSH
• Check Tag
• myši MeSH
• Publikační typ
• klinická studie MeSH
• práce podpořená grantem MeSH